Global RAS-acting Agents Supply, Demand and Key Producers, 2023-2029

May 2023 | 111 pages | ID: GC113B97B965EN
GlobalInfoResearch

Abstracts

The global RAS-acting Agents market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global RAS-acting Agents production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for RAS-acting Agents, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of RAS-acting Agents that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global RAS-acting Agents total production and demand, 2018-2029, (K Units)

Global RAS-acting Agents total production value, 2018-2029, (USD Million)

Global RAS-acting Agents production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global RAS-acting Agents consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: RAS-acting Agents domestic production, consumption, key domestic manufacturers and share

Global RAS-acting Agents production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global RAS-acting Agents production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global RAS-acting Agents production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global RAS-acting Agents market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Pfizer, Inc., AstraZeneca plc, Merck & Co., Inc., Sanofi S.A., Bristol-Myers Squibb Company, Daiichi Sankyo Company, Limited, Takeda Pharmaceutical Company Limited and Boehringer Ingelheim GmbH, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World RAS-acting Agents market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global RAS-acting Agents Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global RAS-acting Agents Market, Segmentation by Type

• ACE Inhibitors
• Angiotensin II Receptor Blockers (ARBs)
• Renin Inhibitors
• Aldosterone Antagonists
• Others (diuretics)

Global RAS-acting Agents Market, Segmentation by Application

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Companies Profiled:

• Novartis AG
• Pfizer, Inc.
• AstraZeneca plc
• Merck & Co., Inc.
• Sanofi S.A.
• Bristol-Myers Squibb Company
• Daiichi Sankyo Company, Limited
• Takeda Pharmaceutical Company Limited
• Boehringer Ingelheim GmbH
• Johnson & Johnson

Key Questions Answered

1. How big is the global RAS-acting Agents market?

2. What is the demand of the global RAS-acting Agents market?

3. What is the year over year growth of the global RAS-acting Agents market?

4. What is the production and production value of the global RAS-acting Agents market?

5. Who are the key producers in the global RAS-acting Agents market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 RAS-acting Agents Introduction
1.2 World RAS-acting Agents Supply & Forecast
  1.2.1 World RAS-acting Agents Production Value (2018 & 2022 & 2029)
  1.2.2 World RAS-acting Agents Production (2018-2029)
  1.2.3 World RAS-acting Agents Pricing Trends (2018-2029)
1.3 World RAS-acting Agents Production by Region (Based on Production Site)
  1.3.1 World RAS-acting Agents Production Value by Region (2018-2029)
  1.3.2 World RAS-acting Agents Production by Region (2018-2029)
  1.3.3 World RAS-acting Agents Average Price by Region (2018-2029)
  1.3.4 North America RAS-acting Agents Production (2018-2029)
  1.3.5 Europe RAS-acting Agents Production (2018-2029)
  1.3.6 China RAS-acting Agents Production (2018-2029)
  1.3.7 Japan RAS-acting Agents Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 RAS-acting Agents Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 RAS-acting Agents Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World RAS-acting Agents Demand (2018-2029)
2.2 World RAS-acting Agents Consumption by Region
  2.2.1 World RAS-acting Agents Consumption by Region (2018-2023)
  2.2.2 World RAS-acting Agents Consumption Forecast by Region (2024-2029)
2.3 United States RAS-acting Agents Consumption (2018-2029)
2.4 China RAS-acting Agents Consumption (2018-2029)
2.5 Europe RAS-acting Agents Consumption (2018-2029)
2.6 Japan RAS-acting Agents Consumption (2018-2029)
2.7 South Korea RAS-acting Agents Consumption (2018-2029)
2.8 ASEAN RAS-acting Agents Consumption (2018-2029)
2.9 India RAS-acting Agents Consumption (2018-2029)

3 WORLD RAS-ACTING AGENTS MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World RAS-acting Agents Production Value by Manufacturer (2018-2023)
3.2 World RAS-acting Agents Production by Manufacturer (2018-2023)
3.3 World RAS-acting Agents Average Price by Manufacturer (2018-2023)
3.4 RAS-acting Agents Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global RAS-acting Agents Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for RAS-acting Agents in 2022
  3.5.3 Global Concentration Ratios (CR8) for RAS-acting Agents in 2022
3.6 RAS-acting Agents Market: Overall Company Footprint Analysis
  3.6.1 RAS-acting Agents Market: Region Footprint
  3.6.2 RAS-acting Agents Market: Company Product Type Footprint
  3.6.3 RAS-acting Agents Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: RAS-acting Agents Production Value Comparison
  4.1.1 United States VS China: RAS-acting Agents Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: RAS-acting Agents Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: RAS-acting Agents Production Comparison
  4.2.1 United States VS China: RAS-acting Agents Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: RAS-acting Agents Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: RAS-acting Agents Consumption Comparison
  4.3.1 United States VS China: RAS-acting Agents Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: RAS-acting Agents Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based RAS-acting Agents Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based RAS-acting Agents Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers RAS-acting Agents Production Value (2018-2023)
  4.4.3 United States Based Manufacturers RAS-acting Agents Production (2018-2023)
4.5 China Based RAS-acting Agents Manufacturers and Market Share
  4.5.1 China Based RAS-acting Agents Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers RAS-acting Agents Production Value (2018-2023)
  4.5.3 China Based Manufacturers RAS-acting Agents Production (2018-2023)
4.6 Rest of World Based RAS-acting Agents Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based RAS-acting Agents Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers RAS-acting Agents Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers RAS-acting Agents Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World RAS-acting Agents Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 ACE Inhibitors
  5.2.2 Angiotensin II Receptor Blockers (ARBs)
  5.2.3 Renin Inhibitors
  5.2.4 Aldosterone Antagonists
  5.2.5 Others (diuretics)
5.3 Market Segment by Type
  5.3.1 World RAS-acting Agents Production by Type (2018-2029)
  5.3.2 World RAS-acting Agents Production Value by Type (2018-2029)
  5.3.3 World RAS-acting Agents Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World RAS-acting Agents Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital Pharmacies
  6.2.2 Retail Pharmacies
  6.2.3 Online Pharmacies
6.3 Market Segment by Application
  6.3.1 World RAS-acting Agents Production by Application (2018-2029)
  6.3.2 World RAS-acting Agents Production Value by Application (2018-2029)
  6.3.3 World RAS-acting Agents Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 Novartis AG
  7.1.1 Novartis AG Details
  7.1.2 Novartis AG Major Business
  7.1.3 Novartis AG RAS-acting Agents Product and Services
  7.1.4 Novartis AG RAS-acting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 Novartis AG Recent Developments/Updates
  7.1.6 Novartis AG Competitive Strengths & Weaknesses
7.2 Pfizer, Inc.
  7.2.1 Pfizer, Inc. Details
  7.2.2 Pfizer, Inc. Major Business
  7.2.3 Pfizer, Inc. RAS-acting Agents Product and Services
  7.2.4 Pfizer, Inc. RAS-acting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 Pfizer, Inc. Recent Developments/Updates
  7.2.6 Pfizer, Inc. Competitive Strengths & Weaknesses
7.3 AstraZeneca plc
  7.3.1 AstraZeneca plc Details
  7.3.2 AstraZeneca plc Major Business
  7.3.3 AstraZeneca plc RAS-acting Agents Product and Services
  7.3.4 AstraZeneca plc RAS-acting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 AstraZeneca plc Recent Developments/Updates
  7.3.6 AstraZeneca plc Competitive Strengths & Weaknesses
7.4 Merck & Co., Inc.
  7.4.1 Merck & Co., Inc. Details
  7.4.2 Merck & Co., Inc. Major Business
  7.4.3 Merck & Co., Inc. RAS-acting Agents Product and Services
  7.4.4 Merck & Co., Inc. RAS-acting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 Merck & Co., Inc. Recent Developments/Updates
  7.4.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
7.5 Sanofi S.A.
  7.5.1 Sanofi S.A. Details
  7.5.2 Sanofi S.A. Major Business
  7.5.3 Sanofi S.A. RAS-acting Agents Product and Services
  7.5.4 Sanofi S.A. RAS-acting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 Sanofi S.A. Recent Developments/Updates
  7.5.6 Sanofi S.A. Competitive Strengths & Weaknesses
7.6 Bristol-Myers Squibb Company
  7.6.1 Bristol-Myers Squibb Company Details
  7.6.2 Bristol-Myers Squibb Company Major Business
  7.6.3 Bristol-Myers Squibb Company RAS-acting Agents Product and Services
  7.6.4 Bristol-Myers Squibb Company RAS-acting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
  7.6.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
7.7 Daiichi Sankyo Company, Limited
  7.7.1 Daiichi Sankyo Company, Limited Details
  7.7.2 Daiichi Sankyo Company, Limited Major Business
  7.7.3 Daiichi Sankyo Company, Limited RAS-acting Agents Product and Services
  7.7.4 Daiichi Sankyo Company, Limited RAS-acting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.7.5 Daiichi Sankyo Company, Limited Recent Developments/Updates
  7.7.6 Daiichi Sankyo Company, Limited Competitive Strengths & Weaknesses
7.8 Takeda Pharmaceutical Company Limited
  7.8.1 Takeda Pharmaceutical Company Limited Details
  7.8.2 Takeda Pharmaceutical Company Limited Major Business
  7.8.3 Takeda Pharmaceutical Company Limited RAS-acting Agents Product and Services
  7.8.4 Takeda Pharmaceutical Company Limited RAS-acting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.8.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
  7.8.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
7.9 Boehringer Ingelheim GmbH
  7.9.1 Boehringer Ingelheim GmbH Details
  7.9.2 Boehringer Ingelheim GmbH Major Business
  7.9.3 Boehringer Ingelheim GmbH RAS-acting Agents Product and Services
  7.9.4 Boehringer Ingelheim GmbH RAS-acting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.9.5 Boehringer Ingelheim GmbH Recent Developments/Updates
  7.9.6 Boehringer Ingelheim GmbH Competitive Strengths & Weaknesses
7.10 Johnson & Johnson
  7.10.1 Johnson & Johnson Details
  7.10.2 Johnson & Johnson Major Business
  7.10.3 Johnson & Johnson RAS-acting Agents Product and Services
  7.10.4 Johnson & Johnson RAS-acting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.10.5 Johnson & Johnson Recent Developments/Updates
  7.10.6 Johnson & Johnson Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 RAS-acting Agents Industry Chain
8.2 RAS-acting Agents Upstream Analysis
  8.2.1 RAS-acting Agents Core Raw Materials
  8.2.2 Main Manufacturers of RAS-acting Agents Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 RAS-acting Agents Production Mode
8.6 RAS-acting Agents Procurement Model
8.7 RAS-acting Agents Industry Sales Model and Sales Channels
  8.7.1 RAS-acting Agents Sales Model
  8.7.2 RAS-acting Agents Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World RAS-acting Agents Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World RAS-acting Agents Production Value by Region (2018-2023) & (USD Million)
Table 3. World RAS-acting Agents Production Value by Region (2024-2029) & (USD Million)
Table 4. World RAS-acting Agents Production Value Market Share by Region (2018-2023)
Table 5. World RAS-acting Agents Production Value Market Share by Region (2024-2029)
Table 6. World RAS-acting Agents Production by Region (2018-2023) & (K Units)
Table 7. World RAS-acting Agents Production by Region (2024-2029) & (K Units)
Table 8. World RAS-acting Agents Production Market Share by Region (2018-2023)
Table 9. World RAS-acting Agents Production Market Share by Region (2024-2029)
Table 10. World RAS-acting Agents Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World RAS-acting Agents Average Price by Region (2024-2029) & (US$/Unit)
Table 12. RAS-acting Agents Major Market Trends
Table 13. World RAS-acting Agents Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World RAS-acting Agents Consumption by Region (2018-2023) & (K Units)
Table 15. World RAS-acting Agents Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World RAS-acting Agents Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key RAS-acting Agents Producers in 2022
Table 18. World RAS-acting Agents Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key RAS-acting Agents Producers in 2022
Table 20. World RAS-acting Agents Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global RAS-acting Agents Company Evaluation Quadrant
Table 22. World RAS-acting Agents Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and RAS-acting Agents Production Site of Key Manufacturer
Table 24. RAS-acting Agents Market: Company Product Type Footprint
Table 25. RAS-acting Agents Market: Company Product Application Footprint
Table 26. RAS-acting Agents Competitive Factors
Table 27. RAS-acting Agents New Entrant and Capacity Expansion Plans
Table 28. RAS-acting Agents Mergers & Acquisitions Activity
Table 29. United States VS China RAS-acting Agents Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China RAS-acting Agents Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China RAS-acting Agents Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based RAS-acting Agents Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers RAS-acting Agents Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers RAS-acting Agents Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers RAS-acting Agents Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers RAS-acting Agents Production Market Share (2018-2023)
Table 37. China Based RAS-acting Agents Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers RAS-acting Agents Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers RAS-acting Agents Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers RAS-acting Agents Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers RAS-acting Agents Production Market Share (2018-2023)
Table 42. Rest of World Based RAS-acting Agents Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers RAS-acting Agents Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers RAS-acting Agents Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers RAS-acting Agents Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers RAS-acting Agents Production Market Share (2018-2023)
Table 47. World RAS-acting Agents Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World RAS-acting Agents Production by Type (2018-2023) & (K Units)
Table 49. World RAS-acting Agents Production by Type (2024-2029) & (K Units)
Table 50. World RAS-acting Agents Production Value by Type (2018-2023) & (USD Million)
Table 51. World RAS-acting Agents Production Value by Type (2024-2029) & (USD Million)
Table 52. World RAS-acting Agents Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World RAS-acting Agents Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World RAS-acting Agents Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World RAS-acting Agents Production by Application (2018-2023) & (K Units)
Table 56. World RAS-acting Agents Production by Application (2024-2029) & (K Units)
Table 57. World RAS-acting Agents Production Value by Application (2018-2023) & (USD Million)
Table 58. World RAS-acting Agents Production Value by Application (2024-2029) & (USD Million)
Table 59. World RAS-acting Agents Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World RAS-acting Agents Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 62. Novartis AG Major Business
Table 63. Novartis AG RAS-acting Agents Product and Services
Table 64. Novartis AG RAS-acting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis AG Recent Developments/Updates
Table 66. Novartis AG Competitive Strengths & Weaknesses
Table 67. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer, Inc. Major Business
Table 69. Pfizer, Inc. RAS-acting Agents Product and Services
Table 70. Pfizer, Inc. RAS-acting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Pfizer, Inc. Recent Developments/Updates
Table 72. Pfizer, Inc. Competitive Strengths & Weaknesses
Table 73. AstraZeneca plc Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca plc Major Business
Table 75. AstraZeneca plc RAS-acting Agents Product and Services
Table 76. AstraZeneca plc RAS-acting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AstraZeneca plc Recent Developments/Updates
Table 78. AstraZeneca plc Competitive Strengths & Weaknesses
Table 79. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Merck & Co., Inc. Major Business
Table 81. Merck & Co., Inc. RAS-acting Agents Product and Services
Table 82. Merck & Co., Inc. RAS-acting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Merck & Co., Inc. Recent Developments/Updates
Table 84. Merck & Co., Inc. Competitive Strengths & Weaknesses
Table 85. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi S.A. Major Business
Table 87. Sanofi S.A. RAS-acting Agents Product and Services
Table 88. Sanofi S.A. RAS-acting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi S.A. Recent Developments/Updates
Table 90. Sanofi S.A. Competitive Strengths & Weaknesses
Table 91. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 92. Bristol-Myers Squibb Company Major Business
Table 93. Bristol-Myers Squibb Company RAS-acting Agents Product and Services
Table 94. Bristol-Myers Squibb Company RAS-acting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bristol-Myers Squibb Company Recent Developments/Updates
Table 96. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
Table 97. Daiichi Sankyo Company, Limited Basic Information, Manufacturing Base and Competitors
Table 98. Daiichi Sankyo Company, Limited Major Business
Table 99. Daiichi Sankyo Company, Limited RAS-acting Agents Product and Services
Table 100. Daiichi Sankyo Company, Limited RAS-acting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Daiichi Sankyo Company, Limited Recent Developments/Updates
Table 102. Daiichi Sankyo Company, Limited Competitive Strengths & Weaknesses
Table 103. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 104. Takeda Pharmaceutical Company Limited Major Business
Table 105. Takeda Pharmaceutical Company Limited RAS-acting Agents Product and Services
Table 106. Takeda Pharmaceutical Company Limited RAS-acting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 108. Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
Table 109. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 110. Boehringer Ingelheim GmbH Major Business
Table 111. Boehringer Ingelheim GmbH RAS-acting Agents Product and Services
Table 112. Boehringer Ingelheim GmbH RAS-acting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 114. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 115. Johnson & Johnson Major Business
Table 116. Johnson & Johnson RAS-acting Agents Product and Services
Table 117. Johnson & Johnson RAS-acting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of RAS-acting Agents Upstream (Raw Materials)
Table 119. RAS-acting Agents Typical Customers
Table 120. RAS-acting Agents Typical Distributors

List Of Figures

LIST OF FIGURES

Figure 1. RAS-acting Agents Picture
Figure 2. World RAS-acting Agents Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World RAS-acting Agents Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World RAS-acting Agents Production (2018-2029) & (K Units)
Figure 5. World RAS-acting Agents Average Price (2018-2029) & (US$/Unit)
Figure 6. World RAS-acting Agents Production Value Market Share by Region (2018-2029)
Figure 7. World RAS-acting Agents Production Market Share by Region (2018-2029)
Figure 8. North America RAS-acting Agents Production (2018-2029) & (K Units)
Figure 9. Europe RAS-acting Agents Production (2018-2029) & (K Units)
Figure 10. China RAS-acting Agents Production (2018-2029) & (K Units)
Figure 11. Japan RAS-acting Agents Production (2018-2029) & (K Units)
Figure 12. RAS-acting Agents Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World RAS-acting Agents Consumption (2018-2029) & (K Units)
Figure 15. World RAS-acting Agents Consumption Market Share by Region (2018-2029)
Figure 16. United States RAS-acting Agents Consumption (2018-2029) & (K Units)
Figure 17. China RAS-acting Agents Consumption (2018-2029) & (K Units)
Figure 18. Europe RAS-acting Agents Consumption (2018-2029) & (K Units)
Figure 19. Japan RAS-acting Agents Consumption (2018-2029) & (K Units)
Figure 20. South Korea RAS-acting Agents Consumption (2018-2029) & (K Units)
Figure 21. ASEAN RAS-acting Agents Consumption (2018-2029) & (K Units)
Figure 22. India RAS-acting Agents Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of RAS-acting Agents by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for RAS-acting Agents Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for RAS-acting Agents Markets in 2022
Figure 26. United States VS China: RAS-acting Agents Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: RAS-acting Agents Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: RAS-acting Agents Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers RAS-acting Agents Production Market Share 2022
Figure 30. China Based Manufacturers RAS-acting Agents Production Market Share 2022
Figure 31. Rest of World Based Manufacturers RAS-acting Agents Production Market Share 2022
Figure 32. World RAS-acting Agents Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World RAS-acting Agents Production Value Market Share by Type in 2022
Figure 34. ACE Inhibitors
Figure 35. Angiotensin II Receptor Blockers (ARBs)
Figure 36. Renin Inhibitors
Figure 37. Aldosterone Antagonists
Figure 38. Others (diuretics)
Figure 39. World RAS-acting Agents Production Market Share by Type (2018-2029)
Figure 40. World RAS-acting Agents Production Value Market Share by Type (2018-2029)
Figure 41. World RAS-acting Agents Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World RAS-acting Agents Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World RAS-acting Agents Production Value Market Share by Application in 2022
Figure 44. Hospital Pharmacies
Figure 45. Retail Pharmacies
Figure 46. Online Pharmacies
Figure 47. World RAS-acting Agents Production Market Share by Application (2018-2029)
Figure 48. World RAS-acting Agents Production Value Market Share by Application (2018-2029)
Figure 49. World RAS-acting Agents Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. RAS-acting Agents Industry Chain
Figure 51. RAS-acting Agents Procurement Model
Figure 52. RAS-acting Agents Sales Model
Figure 53. RAS-acting Agents Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source